Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
Åbacka, Hannah LU
; Hansen, Jesper S
LU
; Huang, Peng
LU
; Venskutonytė, Raminta
LU
; Hyrenius-Wittsten, Axel
LU
; Poli, Giulio
; Tuccinardi, Tiziano
; Granchi, Carlotta
; Minutolo, Filippo
and Hagström-Andersson, Anna K
LU
, et al.
(2021)
In Haematologica
106(4).
p.1163-1166
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/b5b85024-a3ea-4938-8a62-7348f22a52bc
- author
- Åbacka, Hannah
LU
; Hansen, Jesper S
LU
; Huang, Peng
LU
; Venskutonytė, Raminta
LU
; Hyrenius-Wittsten, Axel
LU
; Poli, Giulio
; Tuccinardi, Tiziano
; Granchi, Carlotta
; Minutolo, Filippo
and Hagström-Andersson, Anna K
LU
, et al. (More)
- Åbacka, Hannah
LU
; Hansen, Jesper S
LU
; Huang, Peng
LU
; Venskutonytė, Raminta
LU
; Hyrenius-Wittsten, Axel
LU
; Poli, Giulio
; Tuccinardi, Tiziano
; Granchi, Carlotta
; Minutolo, Filippo
; Hagström-Andersson, Anna K
LU
and Lindkvist-Petersson, Karin
LU
(Less)
- organization
-
- LUCC: Lund University Cancer Centre
- Medical Structural Biology (research group)
- EXODIAB: Excellence of Diabetes Research in Sweden
- Translational Genomic and Functional Studies of Leukemia (research group)
- The pathogenetic mechanisms behind MLL-rearranged acute leukemia in infancy (research group)
- Division of Clinical Genetics
- publishing date
- 2021
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Antimetabolites, Antineoplastic/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cytarabine/therapeutic use, Glucose Transporter Type 1/genetics, Humans, Leukemia, Myeloid, Acute/drug therapy
- in
- Haematologica
- volume
- 106
- issue
- 4
- pages
- 1163 - 1166
- publisher
- Ferrata Storti Foundation
- external identifiers
-
- pmid:32554563
- scopus:85094207537
- ISSN
- 1592-8721
- DOI
- 10.3324/haematol.2020.246843
- language
- English
- LU publication?
- yes
- id
- b5b85024-a3ea-4938-8a62-7348f22a52bc
- date added to LUP
- 2021-12-13 17:07:01
- date last changed
- 2024-06-15 00:31:43
@article{b5b85024-a3ea-4938-8a62-7348f22a52bc,
author = {{Åbacka, Hannah and Hansen, Jesper S and Huang, Peng and Venskutonytė, Raminta and Hyrenius-Wittsten, Axel and Poli, Giulio and Tuccinardi, Tiziano and Granchi, Carlotta and Minutolo, Filippo and Hagström-Andersson, Anna K and Lindkvist-Petersson, Karin}},
issn = {{1592-8721}},
keywords = {{Antimetabolites, Antineoplastic/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cytarabine/therapeutic use; Glucose Transporter Type 1/genetics; Humans; Leukemia, Myeloid, Acute/drug therapy}},
language = {{eng}},
number = {{4}},
pages = {{1163--1166}},
publisher = {{Ferrata Storti Foundation}},
series = {{Haematologica}},
title = {{Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance}},
url = {{http://dx.doi.org/10.3324/haematol.2020.246843}},
doi = {{10.3324/haematol.2020.246843}},
volume = {{106}},
year = {{2021}},
}